CHASE Pharmaceuticals
USEntry
2014
Hold
2yr
Exit
2016
Who owns CHASE Pharmaceuticals?
CHASE Pharmaceuticals was owned by Andera Partners through BioDiscovery 4 (2013 vintage) from 2014 to 2016, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2016
More from BioDiscovery 4
Other portfolio companies in the same fund.
France
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track CHASE Pharmaceuticals
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy CHASE Pharmaceuticals?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on CHASE Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue